Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1 Cyanocyclohexylacetic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104342463B reveals high-purity biocatalytic route. Enhances supply chain reliability and reduces manufacturing costs for gabapentin intermediates significantly for global buyers.
Patent CN105602922A reveals efficient amidase catalysis for gabapentin intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalytic routes.